A health economics researcher explains why purchase price is the smallest number in a clinical trial technology decision and what gets left off the budget.
- Research Design Mistakes Even Experienced Analysts Still Make
- The Infrastructure Behind Virtua Health's Push Toward 1.5 Million Studies A Year
- A Framework For Deploying AI In Clinical Trials Without The Hype
- Why Younger Clinical Researchers Are More Wary Of AI Than Their Elders
- Your EDC Query Count Is Trying To Tell You Something
- Inside The Rush To Accelerated Approval: A Consultant's View
- Why Virtua Health's AI Committee Gives IT The Review, Not The Vote
- Building Effective, Retrospective Decision-Grade Disease Registries
ON-DEMAND WEBINARS
Speakers from Phlexglobal and Regeneron share the benefits of their highly effective partnering model and lessons learned that you can apply in your organization.
As requirements for improved inspection readiness and quality risk management become more critical, discover the need to create a seamless integration and data flow between the eTMF and CTMS.
In this webinar, explore the importance of eCOAs, how they have evolved from the standard paper diaries, and what efficiencies you can realize from them.
Explore key challenges in accessing and preparing analytics-ready clinical data, how FAIR guiding principles can help maximize the value of clinical trial data, and the impact of innovative analytics.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1321462048 AI, research]( "Clinical Research AI: Accelerating Study Design, Validation & Analysis")
Clinical Research AI: Accelerating Study Design, Validation & AnalysisEveryone in clinical research is eager to accelerate progress. Learn how to unlock insights from your data swiftly to accelerate the delivery of safe new therapies.
-
![GettyImages- 1180547354 trial data]( "Simplifying The Data Journey From EHR To EDC")
Simplifying The Data Journey From EHR To EDCExplore how open API architecture represents a significant advancement in the integration of EHR and EDC systems, enhancing the potential of EHR data for clinical research.
-
![Komodo Health - One Day Summit 2023]( "One Day, Clinical Trials Will Represent The Real World")
One Day, Clinical Trials Will Represent The Real WorldWhat needs to happen for RWE to reach its full regulatory potential? We discussed this with industry leaders during the One Day Summit, and here are some key takeaways.
-
![GettyImages-1489414892 Technological Software Engineering Department Manager Using A Laptop]( "Five Ways Site-Facing Technology Helps Sponsors And CROs")
Five Ways Site-Facing Technology Helps Sponsors And CROsSite-facing technology is presented as a crucial enabler of efficient trial execution, aligning site operations with sponsor timelines and objectives.
-
![GettyImages-1224202530 clinical trial tech]( "Why Are Study Builds The Same As Decades Ago?")
Why Are Study Builds The Same As Decades Ago?It seems that we as an industry have held onto a technology mindset that is no longer serving our needs. It’s time to move to a better way. Read our blog on the disconnect between clinical trial technology and legacy habits.
-
![ai-data-GettyImages-2236890597]( "Who Decides? Navigating AI Governance in Clinical Research")
Who Decides? Navigating AI Governance in Clinical ResearchAI in clinical research poses governance challenges. Clear ownership, consistent policies, and aligned teams help manage risk, ensure compliance, and drive responsible innovation in complex trials.
-
![GettyImages-2198078409 - meeting]( "What If Therapeutic Area Expertise Isn't The Competitive Advantage We Think It Is?")
What If Therapeutic Area Expertise Isn't The Competitive Advantage We Think It Is?Rethink vendor evaluation by looking beyond indication experience to discover how cross-trial adaptability, proactive risk management, and team judgment drive true clinical trial resilience.
-
![375_250-clinical_paper_coas_GettyImages-1483251775]( "Paper COAs In 2026? It's Not \"Cheaper,\" It's Riskier")
Paper COAs In 2026? It's Not "Cheaper," It's RiskierPaper-based assessments add operational and regulatory risk — from poor data quality to delayed insights — quietly threatening timelines, compliance, and trial confidence.
-
![workflow improvement-bottlenecking control-GettyImages-1451272908]( "Real-Time Data... Are We Fixing The Right Bottleneck (Or Any For That Matter)?")
Real-Time Data... Are We Fixing The Right Bottleneck (Or Any For That Matter)?Real-time data streaming to regulators is a bold step, but true clinical acceleration requires solving site-level bottlenecks and data silos to reduce the administrative burden on research.
-
eCOA/ePRO: Why Patients Deserve Even More Progress
The shift from reporting on paper to reporting electronically has been happening for years, however, the transition hasn’t always been elegant. Explore how the pandemic has played a role in accelerating the shift to eCOA/ePRO.
- The Hidden Costs Of Clinical Trial Technology Nobody Budgets For
- What South Africa's Trial Sites Teach Global Clinical Research
- Research Design Mistakes Even Experienced Analysts Still Make
- The Infrastructure Behind Virtua Health's Push Toward 1.5 Million Studies A Year
- A Framework For Deploying AI In Clinical Trials Without The Hype
RECENT NEWSLETTERS
- 10.22.26 -- AI, RWE, And IRT Are Exposing Trial Workforce Gaps
- 10.15.26 -- AI, Site Burden, And Vendor Risks Are Testing Trials
- 10.08.26 -- AI, RTSM, And Trial Systems Are Still Breaking Down
- 10.03.26 -- Best Of September: AI, Wearables, And Trial Workflow Gaps
- 10.01.26 -- AI, Data Integrity, And Wireless Gaps Are Reshaping Trials
